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Veterinary Immunology and Immunopathology 120 (2007) 69–79AbstractPost-weaning diarrhoea and oedema disease in weaned piglets are caused by infection with F4+ or F18+ Escherichia coli strains.
There is no commercial vaccine available, but it is shown that oral immunization of weaned piglets with purified F4 fimbriae induces
a protective mucosal immune response. In the present study, piglets were orally and nasally immunized with purified F18 fimbriae in
the presence of the mucosal adjuvant LT(R192G) or CTA1-DD, respectively. This immunization could not lead to protection against
F18+ E. coli infection. The induced F18-specific immune response was directed towards the major subunit FedA and weakly
towards the adhesive subunit FedF. The results of these experiments demonstrate that it is difficult to induce protective immunity
against F18+ E. coli using the whole fimbriae due to the low response against the adhesin.
# 2007 Elsevier B.V. All rights reserved.
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Newly weaned piglets are highly susceptible to F4+
and F18+ enterotoxigenic Escherichia coli (ETEC) and
F18+ verotoxigenic E. coli (VTEC) infections. The F4
and F18 fimbriae of these pathogenic E. coli are
composed of major subunits and different minor
subunits and allow adherence of the bacteria, respec-
tively, to the F4 and F18 receptor (F4R and F18R) on
small intestinal enterocytes (Jones and Rutter, 1972;
Bertschinger et al., 1990; Meijerink et al., 2000).* Corresponding author. Tel.: +32 9 264 73 95; fax: +32 9 264 74 96.
E-mail address: Frank.Verdonck@UGent.be (F. Verdonck).
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doi:10.1016/j.vetimm.2007.06.018However, the adhesive subunit of F4 fimbriae is the
major subunit FaeG, whereas the adhesin of F18
fimbriae is the minor subunit FedF (Bakker et al., 1992;
Imberechts et al., 1996; Smeds et al., 2003). Following
colonization, ETEC strains produce one or more
enterotoxins inducing secretory diarrhoea (Nataro and
Kaper, 1998), whereas VTEC strains produce a
vasotoxin resulting in edema and subsequent neurolo-
gical signs (MacLeod and Gyles, 1991).
F18+ E. coli are widely spread (Verdonck et al.,
2003; Cheng et al., 2005) and are a major cause of
economic losses in the pig industry due to diarrhoea,
growth retardation and mortality. Several methods to
prevent F18+ E. coli infections were examined
(Imberechts et al., 1997; Kyriakis et al., 1997;
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et al., 2000), but no vaccine or good therapy exists to
date. The presence of F18 fimbriae-specific antibodies
by passive immunization or active immunization, was
reported to reduce F18+ E. coli colonization (Bertschin-
ger et al., 2000; Zuniga et al., 1997; Sarrazin and
Bertschinger, 1997).
Previous experiments by our group revealed that
oral immunization of weaned piglets with purified F4
fimbriae, induced an F4-specific systemic and
mucosal immune response protecting these piglets
against a subsequent F4+ ETEC challenge (Van den
Broeck et al., 1999a,b). The aim of the present study
was to analyse whether mucosal immunization of
piglets with purified F18 fimbriae could induce an
active fimbriae-specific immune response, able to
reduce the excretion of F18+ E. coli following an
F18+ VTEC challenge. Piglets were orally or nasally
immunized with purified F18 fimbriae in the presence
or absence of the mucosal adjuvants LT(R192G)
(Dickinson and Clements, 1995) or CTA1-DD (Agren
et al., 1997). LT(R192G) is a mutated variant of LT
that lacks the toxic activity of LT but remains its
adjuvant effect. CTA1-DD is a fusion protein
consisting of the enzymatically active A1 subunit
of CT and two Ig-binding domains of staphylococcal
protein A. This molecule has a strong ADP-
ribosyltransferase activity and can bind to both Fc
and Fab fragments of all classes of antibodies. This
targeting of the adjuvant activity of CT (without its
toxic activity) results in an improved expansion of
activated B cells in the germinal center (Lycke, 2005).
2. Materials and methods
2.1. Pigs
Conventionally bred pigs (Belgian Landra-
ce  Pie´train) were weaned at the age of 3 weeks
(nasal immunization experiment, n = 10) or 4 weeks
(oral immunization experiment, n = 30) and subse-
quently housed in isolation units, fed ad libitum and
treated orally with colistine up to 3 days following
weaning (Promycine pulvis, VMD, Berendonk, Bel-
gium, 150,000 U/kg body weight/day) to prevent E. coli
infections. The piglets were screened to be F18R+ using
the PCR method described by Meijerink et al. (1997) as
well as F18-seronegative using the F18-specific ELISA
(Verdonck et al., 2002). At the end of the experiments,
the presence of the F18R was confirmed using the in
vitro villous adhesion assay (Van den Broeck et al.,
1999c). Adhesion of more than five bacteria per 250 mmvillous length was noted as positive (Cox and
Houvenaghel, 1993).
2.2. Purification of F18 fimbriae and production of
the adhesin FedF
F18 fimbriae were purified as described by Verdonck
et al. (2002). Briefly, bacteria of the F18+ VTEC strain
F107/86 were collected from overnight cultures,
whereafter F18 fimbriae were isolated by heat shock
(60 8C for 20 min) and larger fragments were removed
by two centrifugation steps (20 min 10,000  g and
40 min 20,000  g). The solubilized F18 fimbriae were
precipitated with 20% (w/v) ammonium sulphate and
the pellet was dissolved and dialysed overnight against
ultra pure H2O and stored at 20 8C. The protein
concentration of purified F18 fimbriae was determined
using the bicinchoninic acid reaction with bovine serum
albumin (BSA) as a standard (ICN Biomedicals,
Belgium).
The FedF encoding sequence of strain F107/86 was
cloned in the pET-30 Ek/LIC vector and expression of
recombinant FedF was induced by adding 1 mM
isopropyl-b-D-thiogalactoside (IPTG, Sigma) to over-
night cultures (Tiels et al., 2007). FedF was isolated
from the insoluble cytoplasmatic fraction, further
purified using a Ni-NTA kit (Novagen) and overnight
dialysed against PBS at 4 8C. The protein concentration
of recombinant FedF was determined using the
bicinchoninic acid reaction with bovine serum albumin
(BSA) as a standard (ICN Biomedicals, Belgium).
2.3. Experimental procedure
2.3.1. Oral immunization
Thirty F18-seronegative, F18R+ piglets were ran-
domly divided into five groups of six animals each. One
week post-weaning, four groups of piglets were orally
immunized on 3 subsequent days (0, 1 and 2 days post-
primary immunization, dppi) and again 14 dppi with 10
or 30 mg purified F18 in the absence (10 mg F18 group
and 30 mg F18 group, respectively) or presence of
25 mg LT(R192G) (Dickinson and Clements, 1995)
(10 mg F18 + LT group and 30 mg + LT group,
respectively). The antigen and adjuvant were diluted
in PBS to a final volume of 5 ml. A group of six animals
received PBS (PBS group) and served as negative
control. Before immunization, the animals received
orally 20 mg omeprazole (Losec, Astra Pharmaceuti-
cals, Brussels) to neutralize the acidic gastric pH and to
protect the antigens against possible denaturation
(Snoeck et al., 2004). Three hours before till 2 h after
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water.
One week following the booster immunization, the
animals were challenged on 2 consecutive days (21 and
22 dppi) with the virulent F18+ VTEC strain F107/86
(serotype O139:K12:H1, F18ab+, sLT-IIv+) as pre-
viously described (Verdonck et al., 2002). Briefly, the
pigs were sedated with Stresnil (40 mg/ml; Janssen-
Cilag, Berchem, Belgium), whereafter the gastric pH
was neutralized by intragastrical administration of
62 ml NaHCO3 (1.4% (w/v) in distilled water). After
15–30 min, the piglets were intragastrically inoculated
with 1011 F18+ VTEC (in 10 ml PBS). Faeces were
sampled daily from 2 to 7 days after the first inoculation
(2–7 days post-challenge, dpc) for determining the
faecal excretion of F18+ E. coli. In addition, blood was
sampled 0, 7, 14, 21, 24, 32 and 38 dppi for measuring
the F18- and FedF-specific IgM, IgA and IgG response.
LT(R192G)-specific serum antibodies were analysed at
the moment of challenge. Two weeks following
challenge, the animals were euthanized by intracardial
injection of pentobarbital (24 mg/kg; Nembutal, Sanofi
Sante´ Animale, Brussels, Belgium) and subsequent
exsanguination. Jejunal villi were isolated to confirm
expression of the F18 receptor.
2.3.2. Nasal immunization
Ten F18R+, F18-seronegative pigs were immunized
nasally at 1 week of age, on 3 successive days (0, 1 and 2
dppi) with 1 mg purified F18 fimbriae in the absence
(F18 group, n = 5) or presence of 100 mg CTA1-DD
(Agren et al., 1997) (F18 CTA1-DD group, n = 5), and
again at the moment of weaning (4-week old, 23–25
dppi). The F18 fimbriae and the adjuvant were diluted in
1 ml PBS and administered dropwise into both nostrils.
One week post-weaning (30 and 31 dppi), the pigs were
challenged with the virulent F18+ VTEC strain F107/86
as described above. Faecal excretion of F18+ E. coliwas
determined daily from 2 till 9 dpc. Furthermore, F18-
and FedF-specific IgM, IgA and IgGwere determined in
serum at 0, 23, 30, 37, 39, 44 and 50 dppi. At the
moment of challenge (30 dppi), cholera toxin A subunit-
specific antibodies were analysed in serum and F18-
specific IgM and IgAwere analysed in saliva and nasal
secretion. Euthanasia was performed 3 weeks following
challenge (50 dppi) and jejeunal villi were isolated to
confirm expression of the F18 receptor.
2.4. Analysis of F18+ E. coli excretion
F18+ E. coli were enumerated in faecal samples by
dot blotting as described by Verdonck et al. (2002), withsome modifications. In the present study, suspensions of
faecal samples in PBS were spread onto plain blood
agar plates containing 400 mg/ml streptomycin to select
for the streptomycin resistant F18+ E. coli strain F107/
86 and incubated at 37 8C for 24 h. F18+ E. coli were
detected using the F18(FedA)-specific MAb IMM02
(Tiels et al., 2007) and a horseradish peroxidase (HRP)-
conjugated rabbit anti-mouse immunoglobulin anti-
serum (Dako, Prosan, Merelbeke, Belgium). The
resulting brown-red dots were counted and the average
within each group was calculated.
2.5. Detection of antigen-specific antibodies
Serum, saliva and nasal secretions were sampled as
described (Van den Broeck et al., 1999b; Van der Stede
et al., 2002), to determine antigen-specific serum and
mucosal antibodies. Cholera toxin A subunit-specific
antibodies were analysed as described by Akhiani et al.
(2006).
To detect LT(R192G)-specific antibodies, the wells
of a 96-well microtiter plate (NUNC, Maxisorp
Immuno Plates; Life Technologies, Merelbeke, Bel-
gium) were coated with 5 mg/ml LT(R192G) in PBS
during 2 h at 37 8C. Subsequently, the plates were
blocked overnight at 4 8Cwith 0.2% (v/v) Tween180 in
PBS. Serial 2-fold dilutions of serum samples (starting
from 1/10) in ELISA dilution buffer (PBS + 0.05% (v/
v) Tween120 + 3% (w/v) BSA) were made and
incubated for 1 h at 37 8C. Thereafter, an optimal
dilution of HRP-conjugated rabbit anti-swine (Dako)
was brought on the plate for 1 h at 37 8C. Finally, an
ABTS solution containing H2O2 was added and after
1 h incubation at 37 8C the optical density was
spectrophotometrically measured at 405 nm (OD405).
Between each incubation step, the plates were washed
three times with ELISAwashing buffer (PBS + 0.2% (v/
v) Tween120).
For detection of F18-specific antibodies, the indirect
ELISA described by Verdonck et al. (2002) was used.
Briefly, the wells of a 96-well microtiter plate (NUNC,
Maxisorp) were coated with purified F18 fimbriae in
carbonate–bicarbonate buffer (50 mM, pH 9.4). This
coating with purified F18 fimbriae will mainly result in
the detection of FedA-specific antibodies since purified
F18 fimbriae contain 100–1000 times more FedA major
subunits compared to the minor subunit FedF (unpub-
lished data). After blocking of the remaining binding
sites, serial dilutions of sera, saliva and nasal secretion
were made in ELISA dilution buffer, starting from 1/10,
1/2 and 1/4, respectively. Subsequently, optimal
dilutions of swine-specific IgM, IgA and IgG MAb
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HRP-conjugated serum (Dako) were added. Finally, the
OD405 was spectrophotometrically measured.
FedF-specific antibodies were analysed in an ELISA
identical to the F18 ELISA, except that the plates were
coated with FedF (2 mg/ml in carbonate–bicarbonate
buffer).
The cut-off values were calculated as the mean
OD405-value of all sera (dilution 1/10) at day 0,
increased with three times the standard deviation. The
antibody titer was the inverse of the highest dilution that
still had an OD405 higher than the calculated cut-off
value.
2.6. Statistical analysis
Statistical analysis (SPSS 10.0 for Windows) of F18-
and FedF-specific antibody titers and F18+ E. coli
excretion was done using the General Linear Model
(Repeated Measures Analysis of Variance), adjusting
for multiple comparison by Bonferoni. Differences
between groups in LT(R192G)-specific titer and CT-A-
specifc titer were analysed for statistical significance
using the Mann–Whitney U-test. p < 0.05 was con-
sidered as statistically significant.
3. Results
3.1. Oral immunization of piglets with F18 fimbriae
Primary oral immunization of weaned F18-serone-
gative and F18R+ piglets with 10 or 30 mg purified F18
fimbriae (10 and 30 mg groups, respectively) resulted 2
weeks later (14 dppi) in the appearance of FedF
adhesin-specific IgM, IgA and IgG serum antibodies in
3–4 animals per group (Fig. 1). However, these low
antibody titers are not significantly higher than the
background level of the PBS control group. In the 10
and 30 mg groups, antibodies against purified F18
fimbriae (mainly containing FedA subunits and only
minor amounts of FedF adhesins) were first detected 1
week following the booster immunization (21 dppi).
Oral co-administration of purified F18 fimbriae with
the mucosal adjuvant LT(R192G) (10 mg + LT and
30 mg + LT groups) was not able to clearly improve the
induction of F18- and FedF-specific serum antibodies.
At 21 dppi, only the mean F18-specific IgM titer of the
30 mg + LT group was significantly higher in compar-
ison with the 10, 30 mg and PBS groups ( p  0.038)
(Fig. 1A). The lack of an improved induction of a
fimbriae-specific antibody response is not due to
inactive LT(R192G) since LT-specific total antibodytiters were significantly higher ( p < 0.001) in the
LT(R192G)-supplemented groups (mean titers 320 and
452) at the moment of challenge (21 dppi) than in the
non-supplemented groups where almost no LT-specific
antibodies were detected (mean titers  12). Therefore,
these results show that oral immunization of newly
weaned piglets with purified F18 fimbriae in the
presence or absence of the mucosal adjuvant
LT(R192G) only weakly induces fimbriae-specific
serum antibodies.
One week following the booster immunization (21
dppi), the piglets were challenged on 2 consecutive days
(0 and 1 days post-challenge, dpc) with F18+ VTEC and
F18+ E. coli excretion was determined daily (Fig. 2).
Piglets of the negative control group (PBS group)
excreted between 2.2  107 and 8.4  108 F18+ E. coli
per gram faeces at 2 dpc, which decreased to 0–
8.2  105 F18+ E. coli per gram faeces at 7 dpc. The
excretion in the immunized groups was very similar,
with only a non-significant reduction in the excretion in
the 30 mg + LT group at 5 and 7 dpc. Nevertheless,
these results indicate that oral immunization of newly
weaned piglets with 10 or 30 mg purified F18 fimbriae
in the presence or absence of LT(R192G) did not induce
significant amounts of protective fimbriae-specific
mucosal antibodies.
3.2. Nasal immunization of piglets with F18
fimbriae and CTA1-DD
A second experiment was performed to induce F18-
specific mucosal and systemic antibodies at weaning.
F18-seronegative and F18R+ piglets were immunized
nasally with purified F18 fimbriae in the absence or
presence of the CTA1-DD adjuvant (F18 group and F18
CTA1-DD group, respectively) at 1 week of age and
boosted at weaning. The nasal route was selected since
uptake of milk during suckling can interfere with orally
administered fimbriae and as a consequence interfere
with the induction of a fimbriae-specific immune
response. Furthermore, the CTA1-DD adjuvant has
been shown to be effective in the nasal route (Akhiani
et al., 2006; Dell et al., 2006). One week following
booster immunization (30 dppi), low levels of IgM and
IgG F18-specific and FedF-specific IgM serum anti-
bodies were found in the F18 CTA1-DD group (Fig. 3).
On the other hand, no F18- or FedF-specific serum
antibodies could be detected in animals immunized with
purified F18 without adjuvant. This difference can be
related to the adjuvant effect of CTA1-DD. At the
moment of challenge, all piglets of the CTA1-DD
supplemented group had a CTA-specific serum titer
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Fig. 1. Mean F18-specific IgM (A), IgA (B) and IgG (C) serum antibody titers (S.E.M.) and FedF-specific IgM (D), IgA (E) and IgG (F) serum
antibody titers (S.E.M.) of piglets (n = 6 per group) orally immunized with PBS (PBS group), 10 mg F18 (10 mg group), 30 mg F18 (30 mg group),
10 mg F18 + 25 mg LT(R192G) (10 mg + LT group) and 30 mg F18 + 25 mg LT(R192G) (30 mg + LT group). *Significant difference ( p < 0.05)
between 30 mg + LT group and PBS, 10 mg and 30 mg groups. Black arrow, immunization; white arrow, F18+ VTEC challenge.
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Fig. 2. Mean faecal F18+ E. coli excretion (log 10) per gram faeces (S.E.M.) of piglets (n = 6 per group) orally immunized with PBS (PBS group),
10 mg F18 (10 mg group), 30 mg F18 (30 mg group), 10 mg F18 + 25 mg LT(R192G) (10 mg + LT group) and 30 mg F18 + 25 mg LT(R192G)
(30 mg + LT group).160 whereas the titers in the other group were 20
( p = 0.007). In agreement with the F18-specific serum
response, no significant differences were observed in
IgA and IgM F18-specific antibodies in nasal secretions
and saliva of the F18 and the F18 CTA1-DD groups
(data not shown). However, nasal immunization of
piglets with purified F18 fimbriae in the presence of
CTA1-DD was able to prime a fimbriae-specific
immune response. Indeed, 1 week following an F18+
VTEC challenge (37 dppi), a significant higher F18-
specific IgM antibody titer ( p = 0.012) was found in this
group compared to the F18 group (Fig. 3A). Never-
theless, this priming could not lead to a reduction in
excretion of F18+ E. coli following challenge (Fig. 4).
4. Discussion
In the present study, piglets were immunized
mucosally with purified F18 fimbriae to induce
fimbriae-specific antibodies, inhibiting adhesion of
F18+ E. coli to F18R+ villi. Oral immunization of
piglets with 1 mg purified F4 fimbriae was reported to
induce a protective F4-specific immune response (Van
den Broeck et al., 1999a). However, a preliminary
experiment showed that oral immunization of piglets
with 2 mg purified F18 fimbriae induced a non-
protective F18-specific serum antibody response
(titers < 22) (unpublished data). Also oral immuniza-
tion of piglets with microencapsulated purified F18
fimbriae induced no significant F18-specific serum
antibodies (Felder et al., 2000). Several factors could
account for this difference in immunogenicity between
F18 and F4 fimbriae. A first factor could be the different
structure of both fimbriae. The adhesin of F18 is theminor subunit FedF (Imberechts et al., 1996; Smeds
et al., 2003), whereas the adhesin of F4 fimbriae is the
major fimbrial subunit FaeG (Bakker et al., 1992).
Recent results of our group also suggest that the
interaction between the FedF adhesin and the major
subunit FedA is not as stable as subunit–subunit
interactions in other fimbriae like F4, type 1 and P
pilli (Tiels et al., 2007). This may lead to a lower
capacity of F18 fimbriae than F4 fimbriae to bind to
their specific receptor on intestinal enterocytes, which
may at least partly explain the slower and lower
induction of a fimbriae-specific immune response
following an F18+ VTEC infection as compared with
an F4+ ETEC infection (Verdonck et al., 2002).
Furthermore, the structural difference between both
fimbriae perhaps influences their stability in the
gastrointestinal tract. A second reason for the different
immunogenicity of F4 and F18 could be related with
different properties of the fimbrial receptor or its
localization, but this has to be analysed in further
experiments.
Due to the lower immunogenicity of F18 compared
to F4, doses of 10 and 30 mg purified F18 fimbriae were
used in the present study and a mutant of the heat-labile
enterotoxin, LT(R192G), was used as adjuvant (Dick-
inson and Clements, 1995). Only 30 mg purified F18
fimbriae in the presence of LT(R192G), induced a
significant higher F18-specific IgM serum response (21
dppi) and a low (non-significant) reduction in F18+ E.
coli excretion from 5 dpc onwards. The limited adjuvant
effect of the LT(R192G) in the present study was not
caused by an inactivity of LT(R192G) as high mLT-
specific titers were found in the LT(R192G) immunized
groups and not in the non-immunized group. This
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Fig. 3. Mean F18-specific IgM (A), IgA (B) and IgG (C) serum antibody titers (S.E.M.) and FedF-specific IgM (D), IgA (E) and IgG (F) serum
antibody titers (S.E.M.) of piglets (n = 5 per group) nasally immunizedwith 1 mg F18 (F18 group) or 1 mg F18 + 100 mg CTA1-DD (F18 + CTA1-
ation +adjuvant is reported as a powerful adjuvant for mucosal
immunizations in mice (Gerber et al., 2001; Choi et al.,
2002) and other animals (Burr et al., 2005; Jones et al.,
2006). In pigs, LT(R192G) is shown to be an effective
DD group). *Significant difference ( p < 0.05). Black arrow, immunizadjuvant for nasal immunization (Yuan et al., 2000,
2001), but has not yet been used in oral immunization.
The efficacy of bacterial enterotoxins as adjuvants for
oral immunizations of mice and pigs seems to be
; white arrow, F18 VTEC challenge.
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Fig. 4. Mean faecal F18+ E. coli excretion (log 10) per gram faeces
(S.E.M.) of piglets (n = 5 per group) nasally immunized with 1 mg
purified F18 fimbriae (F18 group) or 1 mg purified F18 fimbriae with
100 mg CTA1-DD (F18 + CTA1-DD group).different. Oral immunization of mice with an antigen in
the presence of cholera toxin (CT) results in the
induction of an antigen-specific immune response
(Clarke et al., 1991; Pierre et al., 1992). In pigs, the
adjuvant activity of CT to orally co-administered
heterologous antigens seems to depend on the antigen
characteristics and the immunization schedule (Foss
and Murtaugh, 1999; Verdonck et al., 2005). In a
previous experiment with a similar immunization
protocol (Verdonck et al., 2005), we observed that oral
co-administration of 50 mg CT and 4.8 mg HSA-HSA
conjugates induced a weak HSA-specific IgG response
21 dppi. Targeting HSA to the intestinal mucosae by the
construction of F4-HSA conjugates and co-administra-
tion with CT, improved the induction of a HSA-specific
immune response. In an oral immunization experiment
of Foss and Murtaugh (1999), CT was only effective as
mucosal adjuvant when keyhole limpet hemocyanin
(KLH) was targeted to the intestinal mucosae (via
binding of KLH to CT-B). Therefore, it would be
interesting to analyse the mucosae-binding potential of
purified F18 following oral administration. F4 is a very
stable protein that will remain largely biologically
active following transit through the stomach (Snoeck
et al., 2004), but the influence of low pH and intestinal
enzymes on F18 fimbriae is not analysed yet. Perhaps,
only the 30 mg dose of F18 fimbriae resulted in
substantial binding of F18 fimbriae to the F18R and
consequent adjuvanticity of LT(R192G).
As oral immunization of newly weaned piglets with
F18 fimbriae in the presence of LT(R192G) was not
effective to prevent F18+ E. coli colonization, a secondexperiment was performed in which piglets were
immunized intranasally. To mimic the field situation,
piglets were already immunized with F18 fimbriae at
the age of 1 week, boosted at weaning and challenged 1
week later, a time point when infections are regularly
seen in the field (Fairbrother et al., 2005). The piglets
were immunized nasally since uptake of milk during
suckling can interfere with binding of fimbriae to their
specific receptor and consequently impair the induction
of fimbriae-specific antibodies (Snoeck et al., 2003). In
addition, lymphocytes sensitized in the nasal-associated
lymphoid tissues can relocate to distant effector sites
such as the lamina propria (Brandtzaeg et al., 1999).
Indeed, Yuan et al. (2000) reported the induction of IgA,
IgM and IgG antigen-specific antibody secreting cells
(3–37 per 5  105 monomorfonuclear cells) in the
intestine following nasal immunization of pigs, despite
the dichotomy in bronchial and intestinal immune
responses (VanCott et al., 1994; Holmgren and
Czerkinsky, 2005). Furthermore, CTA1-DD was used
as adjuvant since it is non-toxic and its adjuvant activity
following nasal administration was reported to be
comparable to that of unmodified CT (Agren et al.,
1998; Eriksson et al., 2004).
In the present study, CTA1-DD had only a slight
adjuvant effect evidenced by the weak antibody
response following the booster immunization and the
significantly higher IgM response in the F18 + CTA1-
DD group. Furthermore, the F18-specific serum anti-
body response increased faster and reached higher titers
in both intranasally groups as compared to the response
seen in an experimental infection of non-immunized
piglets of the same age (Verdonck et al., 2002). These
data suggest that intranasal immunization with F18
fimbriae primed a fimbriae-specific antibody response.
However, the number of fimbriae-specific lymphocytes
in the small intestine was probably low since boosting
of the FedF-specific response was not observed
following the challenge infection, even though there
was a slight rise in the FedF-specific IgM response by
the immunization. This could explain why there was no
significant difference observed in F18+ E. coli excretion
following challenge of piglets immunized intranasally
with F18 fimbriae in the presence or absence of CTA1-
DD and why the excretion followed the pattern seen in
non-immune pigs (Verdonck et al., 2002).
The induced fimbriae-specific immune response is
directed against the F18 major fimbrial subunit FedA
and in a limited extent against the minor adhesive
subunit FedF. Immunizations with type 1 fimbriae
induced a non-protective immune response, mainly
directed against the major subunit FimA (Levine et al.,
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monkeys with recombinant minor adhesive FimH
subunits protects them against uropathogenic E. coli
challenge (Langermann et al., 1997, 2000). In addition,
intramuscular vaccination of chickens with the minor P
pilus subunit and adhesin PapGII induced antibodies
that could inhibit avian pathogenic E. coli binding
(Vandemaele et al., 2006). Recently, oral immunization
with recombinant adhesins is reported to induce a
partial protection (Seo et al., 2002; Verdonck et al.,
2004, 2005). The F18 fimbrial adhesin FedF is
conserved among F18+ E. coli field isolates from
different places around the world (Tiels et al., 2005).
Therefore, oral immunization of piglets with recombi-
nant FedF or its lectin domain (Smeds et al., 2003) has
to be considered.
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